Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
Head Neck. 2011 May;33(5):650-60. doi: 10.1002/hed.21514. Epub 2010 Oct 14.
To the best of our knowledge, no studies to date have evaluated roles of insulin-like growth factor binding protein 5 (IGFBP5) polymorphisms in risk of squamous cell carcinoma of the head and neck (SCCHN).
A hospital-based study of 1082 patients with SCCHN and 1120 cancer-free controls was performed to investigate associations between 2 functional polymorphisms, -1195T>C and -709G>C, in the IGFBP5 promoter region and SCCHN risk.
We demonstrated that the transcription factor, activator protein 1 (AP-1), differentially bound to T or C variants at -1195 in the promoter to regulate the IGFBP5 promoter activity and that the C variant genotypes were associated with deferential risk of late-stage SCCHN, compared to the TT genotype, particularly for human papillomavirus (HPV)-unrelated sites (adjusted odds ratio [OR], 2.21; 95% confidence interval [CI], 1.19-4.11 for CC vs TT).
The IGFBP5 -1195T>C polymorphism is functional and may potentially be a biomarker for susceptibility to late-stage SCCHN.
据我们所知,目前尚无研究评估胰岛素样生长因子结合蛋白 5(IGFBP5)多态性在头颈部鳞状细胞癌(SCCHN)风险中的作用。
对 1082 例 SCCHN 患者和 1120 例无癌对照进行了基于医院的研究,以调查 IGFBP5 启动子区域中-1195T>C 和-709G>C 这两个功能多态性与 SCCHN 风险之间的关联。
我们证明,转录因子激活蛋白 1(AP-1)在启动子处-1195 处与 T 或 C 变体不同地结合,以调节 IGFBP5 启动子活性,并且 C 变体基因型与晚期 SCCHN 的风险降低有关,与 TT 基因型相比,尤其是与人类乳头瘤病毒(HPV)无关的部位(调整后的优势比[OR],2.21;95%置信区间[CI],1.19-4.11,CC 与 TT)。
IGFBP5-1195T>C 多态性是功能性的,可能是晚期 SCCHN 易感性的生物标志物。